Tango Therapeutics
Price & Volume
Stats
See more52W Range | $1.03-$9.70 |
Market Cap | $1.1B |
Shares Short | 29M |
Financials
See moreRevenue (12 Mos) | $66.5M |
Revenue Growth (YoY) | 363.6% |
Gross Profit (12 Mos) | -$67.5M |
Diluted EPS | -$0.91 |
News
See moreYahoo Finance • 2 months ago
Tango Therapeutics to Present First Clinical Data from TNG260 at Society for Immunotherapy of Cancer (SITC) Annual Meeting 2025
Yahoo Finance • 3 months ago
Tango Therapeutics to Participate in the 2025 Cantor Global Healthcare Conference
Yahoo Finance • 4 months ago
Tango Therapeutics Inc (NASDAQ:TNGX) Reports Q2 2025 Earnings: Revenue Misses, EPS Meets Expectations Amid Clinical Progress
Yahoo Finance • 5 months ago
Tango Therapeutics' SWOT analysis: biotech stock's potential in precision cancer therapies
About
CEO | Dr. Barbara L. Weber M.D. |
Address | 201 Brookline Avenue, Boston, MA, United States, 02215 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 155 |
